Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA

被引:231
作者
Glaser, KB [1 ]
Li, JL [1 ]
Staver, MJ [1 ]
Wei, RQ [1 ]
Albert, DH [1 ]
Davidsen, SK [1 ]
机构
[1] Abbott Labs, Global Pharmaceut Res & Dev, Canc Res, Abbott Pk, IL 60064 USA
关键词
siRNA; histone deacetylase (HDAC); apoptosis; proliferation; historic acetylation; chromatin remodeling; historic deacetylase inhibitors; gene knockdown;
D O I
10.1016/j.bbrc.2003.09.043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The role of the individual histone deacetylases (HDACs) in the regulation of cancer cell proliferation was investigated using siRNA-mediated protein knockdown. The siRNA for HDAC3 and HDAC1 demonstrated significant morphological changes in HeLa S3 consistent with those observed with HDAC inhibitors. SiRNA for HDAC 4 or 7 produced no morphological changes in HeLa S3 cells. HDAC1 and 3 siRNA produced a concentration-dependent inhibition of HeLa cell proliferation; whereas, HDAC4 and 7 siRNA showed no effect. HDAC3 siRNA caused historic hyperacetylation and increased the percent of apoptotic cells. These results demonstrate that the Class I HDACs such as HDACs I and 3 are important in the regulation of proliferation and survival in cancer cells. These results and the positive preclinical results with non-specific inhibitors of the HDAC enzymes provide further support for the development of Class I selective HDAC inhibitors as cancer therapeutics. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:529 / 536
页数:8
相关论文
共 39 条
[1]
AKIYOSHI S, 1999, J BIOL CHEM
[2]
Genomewide studies of histone deacetylase function in yeast [J].
Bernstein, BE ;
Tong, JK ;
Schreiber, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (25) :13708-13713
[3]
Butler LM, 2000, CANCER RES, V60, P5165
[4]
Cohen LA, 1999, ANTICANCER RES, V19, P4999
[5]
Davie JR, 2001, PROG NUCLEIC ACID RE, V65, P299
[6]
Enzymatic activity associated with class IIHDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR [J].
Fischle, W ;
Dequiedt, F ;
Hendzel, MJ ;
Guenther, MG ;
Lazar, MA ;
Voelter, W ;
Verdin, E .
MOLECULAR CELL, 2002, 9 (01) :45-57
[7]
Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin [J].
Furumai, R ;
Komatsu, Y ;
Nishino, N ;
Khochbin, S ;
Yoshida, M ;
Horinouchi, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :87-92
[8]
Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family [J].
Gao, L ;
Cueto, MA ;
Asselbergs, F ;
Atadja, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) :25748-25755
[9]
Glaser KB, 2002, MOL CANCER THER, V1, P759
[10]
Glaser KB, 2003, MOL CANCER THER, V2, P151